A
AnaptysBio, Inc. (ANAB)
NMS – Real Time Price. Currency in USD
65.58
-2.34 (-3.45%)
At close: May 12, 2026, 4:00 PM EDT
65.99
+0.41 (0.63%)
After-hours: May 12, 2026, 7:57 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
65.58
-2.34 (-3.45%)
At close: May 12, 2026, 4:00 PM EDT
65.99
+0.41 (0.63%)
After-hours: May 12, 2026, 7:57 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.07 | 6.05 | 10 | |
| Quick ratio | 9.07 | 5.63 | 10 | |
| Debt to Equity | 7.81 | 0.30 | 2.0 | |
| Debt to Assets | 0.80 | 1.04 | 2.0 | |
| Interest coverage | 3.39 | -16.91 | 8.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 10M | 17M | 91M | 235M | 235M |
| Gross Profit | 8M | 15M | 89M | 232M | 232M |
| Operating Income | -115M | -157M | -115M | 48M | 48M |
| Net Income | -129M | -164M | -145M | -13M | -13M |
| EBITDA | -113M | -155M | -113M | 50M | 50M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -32.08 | 24.57 | 5.5 |
| Next quarter | -8.1 | 46.16 | 5.5 |
| Current year | -57.1 | -584.34 | 1.0 |
| Next year | 68.75 | -11.66 | 5.5 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 41.84 | 228.29 | 203.85 | 458.07 | 10 |
| Y/Y | 151.08 | 327.75 | 319.44 | 246.18 | 10 |
| 3y average | 218.61 | 25.01 | 24.59 | 12.78 | 9.5 |
| 5y average | 111.27 | -47.52 | -46.36 | -47.82 | 3.3 |
| Weighted average score | 8.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $290.6M significantly exceeds cash reserves ($238.2M), raising financial stability concerns
Total current assets $350.2M exceed Total current liabilities $38.6M, highlighting excellent liquidity
Debt-to-equity ratio (7.8) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (3x) is sufficient but not particularly strong
The company generates positive free cash flow $98.0M, supporting its financial health